Medicare Enrolled

Dr. Pradip Morbia, MD

Cardiovascular Disease · Port Arthur, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3921 N TWIN CITY HWY, Port Arthur, TX 77642
4099630000
In practice since 2005 (20 years)
NPI: 1396740239 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Morbia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Morbia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Morbia

Dr. Pradip Morbia is a cardiovascular disease in Port Arthur, TX, with 20 years in practice. Based on federal Medicare data, Dr. Morbia performed 7,854 Medicare services across 4,290 unique beneficiaries.

Between the years covered by Open Payments, Dr. Morbia received a total of $3,133 from 28 pharmaceutical and/or device companies across 125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Morbia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 6% volume in TX$ $3,133 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,854
Medicare services
Top 6% in TX for cardiovascular disease
4,290
Unique beneficiaries
$120
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~393 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,376$92$353
Regadenoson injection (Lexiscan) for heart stress test1,208$43$119
Electrocardiogram (EKG), 12-lead687$10$39
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional400$16$62
Echocardiogram, transthoracic389$117$475
Ultrasound of both sides of head and neck blood flow326$131$509
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician309$52$193
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries302$291$1,291
Testing of autonomic nervous system function and heart rate response to deep breathing256$63$240
Testing of autonomic (sympathetic) nervous system function255$91$336
Electrocardiogram (ecg) 1 to 3 leads with review by physician254$9$35
Nuclear medicine studies of blood flow in heart muscle at rest and with stress249$1,051$3,795
Ultrasound study of arm or leg veins with compression and maneuvers192$111$406
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional178$46$196
Office visit, established patient, complex (40-54 min)139$131$478
Remote pacemaker monitoring, 90 days122$20$84
Office visit, established patient (20-29 min)106$63$252
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes106$30$112
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional96$612$2,248
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional91$19$70
Remote patient monitoring management, 20 min/month89$36$137
Evaluation of cardiac rhythm monitor system, remote up to 30 days85$18$72
Anticoagulant management of patient taking warfarin80$8$33
Complete ultrasound study of arm and leg arteries73$82$347
Ultrasound of leg arteries at rest and after exercise72$111$419
Remote patient monitoring device, 30 days64$35$136
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan51$1,750$6,793
New patient office visit (45-59 min)48$107$457
Cardiac catheterization47$208$843
Injection, aminophyllin, up to 250 mg45$7$19
Programming of dual lead pacemaker system37$52$215
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes27$8$30
Review by radiologist of both arms or legs arteries image20$57$6,967
New patient office visit, complex (60-74 min)18$158$614
Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist16$260$1,014
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes16$33$499
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment13$13$53
Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional12$122$504
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.6% high complexity
32.1% medium
60.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,133
Total received (2018-2024)
Avg $448/year across 7 years
Bottom 40% in TX for cardiovascular disease
28
Companies
125
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,133 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,400
2023
$542
2022
$246
2021
$324
2020
$125
2019
$202
2018
$294

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Endologix LLC
$1,013
Abbott Laboratories
$273
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$225
Merck Sharp & Dohme LLC
$213
E.R. Squibb & Sons, L.L.C.
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$136
Novartis Pharmaceuticals Corporation
$133
Janssen Pharmaceuticals, Inc
$120
Medtronic, Inc.
$106
AngioDynamics, Inc.
$91
Boston Scientific Corporation
$90
Merck Sharp & Dohme Corporation
$80
BOSTON SCIENTIFIC CORPORATION
$71
ShockWave Medical, Inc
$58
Amgen Inc.
$53
Astellas Pharma US Inc
$40
BIOTRONIK INC.
$38
VivaQuant Inc, dba Rhythm Express
$32
Actelion Pharmaceuticals US, Inc.
$25
PFIZER INC.
$22
Lexicon Pharmaceuticals, Inc.
$21
CORDIS US CORP.
$19
SANOFI-AVENTIS U.S. LLC
$16
Novo Nordisk Inc
$15
Regeneron Healthcare Solutions, Inc.
$13
Siemens Medical Solutions USA, Inc.
$11
iRhythm Technologies, Inc.
$11
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 48.2% of total payments
Associated products mentioned in payments ›
ADVANTIO · Artis zee · Azure · BELSOMRA · CAMZYOS · CARDIOMEMS · Carnation Ambulatory Monitor · Claria MRI · Corlanor · DIAMONDBACK PERIPHERAL · ELIQUIS · ENDOCROSS Device · ENSITE PRECISION · ENTRESTO · HeartMate 3 Left Ventricular Dev · INGEVITY · Inpefa · JARDIANCE · LATITUDE · LATITUDE CLARITY · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · LifeVest · MITRACLIP · MULTAQ · MYNXGRIP · MitraClip System · NA · OPSUMIT · Ozempic · PRADAXA · PRALUENT ALIROCUMAB INJECTION · Repatha · Rhythm Express · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Torus Stent Graft System · VERQUVO · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $40 per 100 Medicare services performed
Looking for a cardiovascular disease in Port Arthur?
Compare cardiovascular diseases in the Port Arthur area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
17
Per 100K population
6.7
County median income
$59,934
Nearest hospital
THE MEDICAL CENTER OF SOUTHEAST TEXAS
6.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Morbia is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Morbia experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Morbia performed 1,376 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Morbia receive payments from pharmaceutical companies?
Yes. Dr. Morbia received a total of $3,133 from 28 companies across 125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Morbia's costs compare to other cardiovascular diseases in Port Arthur?
Dr. Morbia's average Medicare payment per service is $120. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Morbia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →